| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |